Malaria News and Research

Latest Malaria News and Research

PINC trial to test anti-malarial drug in women with DCIS

Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.

3 Mar 2010

Opinions: Chile's preparedness; Evangelical Christians; 'Locavorism'

The earthquake in Chile "was the fifth biggest ever measured, and several hundred times larger than the one that killed more than 220,000 in Haiti," according to a Wall Street Journal editorial. The editorial highlights Chile's preparation for earthquakes, including stricter building codes. "But such preparation is also the luxury of a prosperous country, in contrast to destitute and ill-governed Haiti.

3 Mar 2010

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced its accelerated timetable for delivery of the world's first handheld, integrated optical biosensor.

3 Mar 2010

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor’s TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.

3 Mar 2010

Problems controlling common diseases could be hindering efforts to meet key child health goals

Problems controlling common diseases like HIV, heart disease and diabetes in poor countries could be hindering efforts to meet the world's key child health and tuberculosis goals, a new study published in PLoS Medicine has warned.

2 Mar 2010

News outlets examine development of low-cost diagnostic tool, infectious disease surveillance

CNN examines the work of a Harvard University chemistry professor to "shrink a medical laboratory onto a piece of paper that's the size of a fingerprint and costs about a penny." According to George Whitesides, who created a prototype of the inexpensive paper "chip," the technology could be used to diagnose such diseases as HIV, malaria and tuberculosis in developing countries.

2 Mar 2010

Joint Chiefs Chair visits Haiti to examine aid response

Joint Chiefs of Staff Chair Mike Mullen, who is President Barack Obama's top military adviser, visited Haiti over the weekend to examine relief and rebuilding efforts and meet with local leaders, Agence France-Presse reports. It was his first visit to the country after the earthquake, according to AFP.

2 Mar 2010

Surge in volunteers without overall coordination can make devastating situation worse instead of better

A surge in volunteers following a major disaster can overwhelm a response system, and without overall coordination, can actually make a situation worse instead of better. The outpouring of medical volunteers who responded to the devastating earthquake that rocked Haiti in January provides a roadmap for health care providers during future disasters, say the authors of a New England Journal of Medicine "Perspectives" piece that will be published online February 24.

26 Feb 2010

Antiretroviral therapy reduces mortality rates in patients co-infected with HIV and TB

Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which provides further impetus for the integration of TB and HIV services, lays to rest the controversy on whether co-infected patients should initiate ART during or after TB treatment.

26 Feb 2010

Campaign to stop sale of electronic mosquito repellents by major airlines begins to bear fruit

A campaign to stop the sale of electronic mosquito repellents by major airlines is beginning to bear fruit with the immediate withdrawal of the products from KLM flights. The issue being that these electronic repellents, sold to airline passengers, many on their way to malaria endemic countries, just don't work.

25 Feb 2010

LGL awards first three grants from POC fund for research in immunotherapy, schizophrenia and heart disease

London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, has awarded the first three grants from its proof-of-concept (POC) fund. The awards, to teams at Imperial College London and University College London, are for research in the areas of immunotherapy, schizophrenia and heart disease.

25 Feb 2010

GAA urges Obama to continue support for global health programs

The Global AIDS Alliance (GAA) calls on the Obama Administration to fully fund its development priorities and to continue U.S. Leadership in the fight against HIV/AIDS as an integral part of President Obama's Global Health Initiative.

25 Feb 2010

Mouse study provides new way to test novel therapies for liver infections

How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver.

24 Feb 2010

Flightless mosquitoes could fight dengue, study says

By rendering female Aedes aegypti mosquitoes - the dengue virus vector - unable to fly, scientists say they may be able to slow the spread of the virus which experts believe "affects up to 100 million people a year and threatens over a third of the world's population," the BBC reports. Currently, there is no treatment for dengue nor a vaccine to protect against the virus.

24 Feb 2010

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

Longhorn Vaccines & Diagnostics today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ in CLIA high complexity laboratories. . The Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ is a ready-use assay that requires no mixing prior to use and has been authorized for use on the ABI 7500.

24 Feb 2010

Also in global health news: Global Fund; MDGs, women; polio eradication

Radio Australia examines the Global Fund to Fight AIDS, Tuberculosis and Malaria's push for more funding from Australia and China. Global Fund Executive Director "Michel Kazatchkine is currently touring the world's capitals seeking renewed government pledges to build on an already impressive record and as well as looking to Australia to do more, he's hoping soon to get China to become not just recipient, but donor."

24 Feb 2010

Blair talks about combating malaria in Nigeria, part of 3-nation African trip

"Former British prime minister Tony Blair on Saturday called for concerted efforts to combat malaria in Nigeria which accounts for a quarter of the [nearly] one million malaria deaths annually in Africa," Agence France-Presse writes (2/20).

23 Feb 2010

Also in global health news: Infant, maternal mortality in N. Korea; malaria in Cambodia; Zambia PEPFAR program; Pakistan's anti-polio campaign; U.N. Ambassador responds to Somalia; Myanmar refugees

Higher rates of infant and maternal mortality have lead to a decline of life expectancy in North Korea over the past 15 years, census figures, which were obtained with help form the U.N. Population Fund, said on Monday, Agence France-Presse reports (2/22).

23 Feb 2010

Haitian President says up to 300,000 people could have died in quake

The major earthquake in January in Haiti could have killed as many as 300,000 people, an estimate that includes bodies buried in the rubble, Haitian President Rene Preval said on Sunday at a meeting of Latin American and Caribbean leaders in Mexico, Reuters reports.

23 Feb 2010

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

Sanaria Inc. has received additional support from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in the form of a Phase II Small Business Innovation Research (SBIR) Grant. The three-year award totaling approximately $3 million will support collaborative research by investigators at Sanaria and Columbia University.

23 Feb 2010

Malaria News and Research

Latest Malaria News and Research

PINC trial to test anti-malarial drug in women with DCIS

Opinions: Chile's preparedness; Evangelical Christians; 'Locavorism'

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Problems controlling common diseases could be hindering efforts to meet key child health goals

News outlets examine development of low-cost diagnostic tool, infectious disease surveillance

Joint Chiefs Chair visits Haiti to examine aid response

Surge in volunteers without overall coordination can make devastating situation worse instead of better

Antiretroviral therapy reduces mortality rates in patients co-infected with HIV and TB

Campaign to stop sale of electronic mosquito repellents by major airlines begins to bear fruit

LGL awards first three grants from POC fund for research in immunotherapy, schizophrenia and heart disease

GAA urges Obama to continue support for global health programs

Mouse study provides new way to test novel therapies for liver infections

Flightless mosquitoes could fight dengue, study says

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

Also in global health news: Global Fund; MDGs, women; polio eradication

Blair talks about combating malaria in Nigeria, part of 3-nation African trip

Also in global health news: Infant, maternal mortality in N. Korea; malaria in Cambodia; Zambia PEPFAR program; Pakistan's anti-polio campaign; U.N. Ambassador responds to Somalia; Myanmar refugees

Haitian President says up to 300,000 people could have died in quake

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Malaria News and Research

Latest Malaria News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in